[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fLXN4j_kd6g_s06Ylf5bENhc-bxKUVakRPbWehAwYnis":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":34,"phaseBuckets":60,"rows":67},"Hopital Foch",[4],210,false,20,9,43888,164,[13,16,19,22,24,27,30,32],{"name":14,"count":15},"Anesthesia",27,{"name":17,"count":18},"Pain",8,{"name":20,"count":21},"Surgery",7,{"name":23,"count":21},"Anesthesia, General",{"name":25,"count":26},"General Anesthesia",6,{"name":28,"count":29},"Bladder Cancer",4,{"name":31,"count":29},"Covid19",{"name":33,"count":29},"Lung Transplant",[35,40,45,50,55],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05329090","Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis","2025-07-16","Rituximab",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04356664","Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and\u002For Adenomyosis","2026-06-18","GnRH agonist",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06294847","Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery","2027-05","Ursolvan",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT06757244","DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer","2028-02-18","Dostarlimab",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT04945148","Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide","2028-05","Metformin",[61,62,63,64,65,66],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[68,94,116,139,161,179,203,221,239,257,293,318,336,361,387,405,431,454,472,497,515,542,560,578,596,614,642,660,678,696,714,732,758,782,800,823,849,882,906,924,942,960,985,1011,1066,1100,1131,1157,1180,1198,1223,1249,1275,1293,1318,1340,1364,1389,1415,1438,1467,1492,1516,1541],{"intervention":44,"totalTrials":69,"cells":70},1,{"EARLY_PHASE1":71,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":90,"NA":92},{"trials":72,"activeCount":73},[],0,{"trials":75,"activeCount":73},[],{"trials":77,"activeCount":73},[],{"trials":79,"activeCount":69,"soonestReadout":43},[80],{"nctId":41,"briefTitle":42,"status":81,"phases":82,"primaryCompletion":43,"completion":43,"start":83,"enrollment":84,"conditions":85,"interventions":89},"RECRUITING",[63,64],"2021-03-18",180,[86,87,88],"Endometriosis","Adenomyosis","Infertility, Female",[44],{"trials":91,"activeCount":73},[],{"trials":93,"activeCount":73},[],{"intervention":49,"totalTrials":69,"cells":95},{"EARLY_PHASE1":96,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":112,"NA":114},{"trials":97,"activeCount":73},[],{"trials":99,"activeCount":73},[],{"trials":101,"activeCount":73},[],{"trials":103,"activeCount":69,"soonestReadout":48},[104],{"nctId":46,"briefTitle":47,"status":81,"phases":105,"primaryCompletion":48,"completion":106,"start":107,"enrollment":108,"conditions":109,"interventions":111},[64],"2027-11","2024-08-20",120,[110],"Retinal Detachment",[49],{"trials":113,"activeCount":73},[],{"trials":115,"activeCount":73},[],{"intervention":39,"totalTrials":69,"cells":117},{"EARLY_PHASE1":118,"PHASE1":120,"PHASE2":122,"PHASE3":124,"PHASE4":135,"NA":137},{"trials":119,"activeCount":73},[],{"trials":121,"activeCount":73},[],{"trials":123,"activeCount":73},[],{"trials":125,"activeCount":69,"soonestReadout":38},[126],{"nctId":36,"briefTitle":37,"status":127,"phases":128,"primaryCompletion":38,"completion":129,"start":130,"enrollment":131,"conditions":132,"interventions":134},"ACTIVE_NOT_RECRUITING",[64],"2026-01-16","2022-03-11",75,[133],"IgA Vasculitis",[39],{"trials":136,"activeCount":73},[],{"trials":138,"activeCount":73},[],{"intervention":59,"totalTrials":69,"cells":140},{"EARLY_PHASE1":141,"PHASE1":143,"PHASE2":145,"PHASE3":155,"PHASE4":157,"NA":159},{"trials":142,"activeCount":73},[],{"trials":144,"activeCount":73},[],{"trials":146,"activeCount":69,"soonestReadout":58},[147],{"nctId":56,"briefTitle":57,"status":81,"phases":148,"primaryCompletion":58,"completion":58,"start":149,"enrollment":150,"conditions":151,"interventions":153},[63],"2024-05-10",640,[152],"Glioblastoma, IDH-wildtype",[59,154],"Temozolomide",{"trials":156,"activeCount":73},[],{"trials":158,"activeCount":73},[],{"trials":160,"activeCount":73},[],{"intervention":154,"totalTrials":69,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":173,"PHASE4":175,"NA":177},{"trials":164,"activeCount":73},[],{"trials":166,"activeCount":73},[],{"trials":168,"activeCount":69,"soonestReadout":58},[169],{"nctId":56,"briefTitle":57,"status":81,"phases":170,"primaryCompletion":58,"completion":58,"start":149,"enrollment":150,"conditions":171,"interventions":172},[63],[152],[59,154],{"trials":174,"activeCount":73},[],{"trials":176,"activeCount":73},[],{"trials":178,"activeCount":73},[],{"intervention":54,"totalTrials":69,"cells":180},{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":197,"PHASE4":199,"NA":201},{"trials":182,"activeCount":73},[],{"trials":184,"activeCount":73},[],{"trials":186,"activeCount":69,"soonestReadout":53},[187],{"nctId":51,"briefTitle":52,"status":81,"phases":188,"primaryCompletion":53,"completion":53,"start":189,"enrollment":190,"conditions":191,"interventions":193},[63],"2025-02-18",35,[192],"Pancreas Neoplasms",[54,194,195,196],"Vitamin D3","mFOLFIRINOX Treatment Regimen","LV5FU2",{"trials":198,"activeCount":73},[],{"trials":200,"activeCount":73},[],{"trials":202,"activeCount":73},[],{"intervention":194,"totalTrials":69,"cells":204},{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":215,"PHASE4":217,"NA":219},{"trials":206,"activeCount":73},[],{"trials":208,"activeCount":73},[],{"trials":210,"activeCount":69,"soonestReadout":53},[211],{"nctId":51,"briefTitle":52,"status":81,"phases":212,"primaryCompletion":53,"completion":53,"start":189,"enrollment":190,"conditions":213,"interventions":214},[63],[192],[54,194,195,196],{"trials":216,"activeCount":73},[],{"trials":218,"activeCount":73},[],{"trials":220,"activeCount":73},[],{"intervention":195,"totalTrials":69,"cells":222},{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":233,"PHASE4":235,"NA":237},{"trials":224,"activeCount":73},[],{"trials":226,"activeCount":73},[],{"trials":228,"activeCount":69,"soonestReadout":53},[229],{"nctId":51,"briefTitle":52,"status":81,"phases":230,"primaryCompletion":53,"completion":53,"start":189,"enrollment":190,"conditions":231,"interventions":232},[63],[192],[54,194,195,196],{"trials":234,"activeCount":73},[],{"trials":236,"activeCount":73},[],{"trials":238,"activeCount":73},[],{"intervention":196,"totalTrials":69,"cells":240},{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":251,"PHASE4":253,"NA":255},{"trials":242,"activeCount":73},[],{"trials":244,"activeCount":73},[],{"trials":246,"activeCount":69,"soonestReadout":53},[247],{"nctId":51,"briefTitle":52,"status":81,"phases":248,"primaryCompletion":53,"completion":53,"start":189,"enrollment":190,"conditions":249,"interventions":250},[63],[192],[54,194,195,196],{"trials":252,"activeCount":73},[],{"trials":254,"activeCount":73},[],{"trials":256,"activeCount":73},[],{"intervention":258,"totalTrials":259,"cells":260},"Ketamine",2,{"EARLY_PHASE1":261,"PHASE1":263,"PHASE2":265,"PHASE3":267,"PHASE4":279,"NA":291},{"trials":262,"activeCount":73},[],{"trials":264,"activeCount":73},[],{"trials":266,"activeCount":73},[],{"trials":268,"activeCount":73},[269],{"nctId":270,"briefTitle":271,"status":272,"phases":273,"primaryCompletion":274,"completion":274,"start":275,"enrollment":276,"conditions":277,"interventions":278},"NCT02011347","Ketamine and Closed-Loop Anesthesia System","TERMINATED",[64],"2015-10-07","2013-07",67,[14],[258],{"trials":280,"activeCount":73},[281],{"nctId":282,"briefTitle":283,"status":272,"phases":284,"primaryCompletion":285,"completion":285,"start":286,"enrollment":259,"conditions":287,"interventions":289},"NCT01320475","Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine",[65],"2011-07","2010-09",[288],"Thoracic Surgery",[290,258],"Sufentanil",{"trials":292,"activeCount":73},[],{"intervention":294,"totalTrials":69,"cells":295},"Gelatin 500 mL",{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":302,"PHASE4":304,"NA":316},{"trials":297,"activeCount":73},[],{"trials":299,"activeCount":73},[],{"trials":301,"activeCount":73},[],{"trials":303,"activeCount":73},[],{"trials":305,"activeCount":73},[306],{"nctId":307,"briefTitle":308,"status":272,"phases":309,"primaryCompletion":310,"completion":310,"start":311,"enrollment":312,"conditions":313,"interventions":314},"NCT01594021","Efficacy of Preemptive Volume Loading to Prevent Arterial Hypotension During Induction of General Anesthesia",[65],"2014-06","2012-07",17,[14],[294,315],"Gelatin 50 mL",{"trials":317,"activeCount":73},[],{"intervention":315,"totalTrials":69,"cells":319},{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":326,"PHASE4":328,"NA":334},{"trials":321,"activeCount":73},[],{"trials":323,"activeCount":73},[],{"trials":325,"activeCount":73},[],{"trials":327,"activeCount":73},[],{"trials":329,"activeCount":73},[330],{"nctId":307,"briefTitle":308,"status":272,"phases":331,"primaryCompletion":310,"completion":310,"start":311,"enrollment":312,"conditions":332,"interventions":333},[65],[14],[294,315],{"trials":335,"activeCount":73},[],{"intervention":337,"totalTrials":69,"cells":338},"Sugammadex",{"EARLY_PHASE1":339,"PHASE1":341,"PHASE2":343,"PHASE3":345,"PHASE4":347,"NA":359},{"trials":340,"activeCount":73},[],{"trials":342,"activeCount":73},[],{"trials":344,"activeCount":73},[],{"trials":346,"activeCount":73},[],{"trials":348,"activeCount":73},[349],{"nctId":350,"briefTitle":351,"status":352,"phases":353,"primaryCompletion":354,"completion":354,"start":355,"enrollment":356,"conditions":357,"interventions":358},"NCT01579851","Recovery After Sugammadex(Propofol vs Sevoflurane)","COMPLETED",[65],"2015-01","2012-01",71,[14],[337],{"trials":360,"activeCount":73},[],{"intervention":362,"totalTrials":69,"cells":363},"Ixprim®",{"EARLY_PHASE1":364,"PHASE1":366,"PHASE2":368,"PHASE3":370,"PHASE4":372,"NA":385},{"trials":365,"activeCount":73},[],{"trials":367,"activeCount":73},[],{"trials":369,"activeCount":73},[],{"trials":371,"activeCount":73},[],{"trials":373,"activeCount":73},[374],{"nctId":375,"briefTitle":376,"status":352,"phases":377,"primaryCompletion":378,"completion":379,"start":380,"enrollment":381,"conditions":382,"interventions":383},"NCT01782846","Trama-Code (Two Analgesics-comparative Study)",[65],"2013-02","2013-04","2011-03",803,[17],[362,384],"Dafalgan-Codeine®",{"trials":386,"activeCount":73},[],{"intervention":384,"totalTrials":69,"cells":388},{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":403},{"trials":390,"activeCount":73},[],{"trials":392,"activeCount":73},[],{"trials":394,"activeCount":73},[],{"trials":396,"activeCount":73},[],{"trials":398,"activeCount":73},[399],{"nctId":375,"briefTitle":376,"status":352,"phases":400,"primaryCompletion":378,"completion":379,"start":380,"enrollment":381,"conditions":401,"interventions":402},[65],[17],[362,384],{"trials":404,"activeCount":73},[],{"intervention":406,"totalTrials":69,"cells":407},"Dexamethasone and Ondansetron",{"EARLY_PHASE1":408,"PHASE1":410,"PHASE2":412,"PHASE3":414,"PHASE4":416,"NA":429},{"trials":409,"activeCount":73},[],{"trials":411,"activeCount":73},[],{"trials":413,"activeCount":73},[],{"trials":415,"activeCount":73},[],{"trials":417,"activeCount":73},[418],{"nctId":419,"briefTitle":420,"status":352,"phases":421,"primaryCompletion":422,"completion":423,"start":424,"enrollment":425,"conditions":426,"interventions":428},"NCT01876290","Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting",[65],"2014-01","2015-03","2013-05",122,[427],"Postoperative Nausea and Vomiting",[406],{"trials":430,"activeCount":73},[],{"intervention":432,"totalTrials":69,"cells":433},"succinylcholine",{"EARLY_PHASE1":434,"PHASE1":436,"PHASE2":438,"PHASE3":440,"PHASE4":442,"NA":452},{"trials":435,"activeCount":73},[],{"trials":437,"activeCount":73},[],{"trials":439,"activeCount":73},[],{"trials":441,"activeCount":73},[],{"trials":443,"activeCount":73},[444],{"nctId":445,"briefTitle":446,"status":272,"phases":447,"primaryCompletion":448,"completion":448,"start":355,"enrollment":26,"conditions":449,"interventions":450},"NCT01579864","Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia",[65],"2015-06",[14],[432,451],"rocuronium",{"trials":453,"activeCount":73},[],{"intervention":451,"totalTrials":69,"cells":455},{"EARLY_PHASE1":456,"PHASE1":458,"PHASE2":460,"PHASE3":462,"PHASE4":464,"NA":470},{"trials":457,"activeCount":73},[],{"trials":459,"activeCount":73},[],{"trials":461,"activeCount":73},[],{"trials":463,"activeCount":73},[],{"trials":465,"activeCount":73},[466],{"nctId":445,"briefTitle":446,"status":272,"phases":467,"primaryCompletion":448,"completion":448,"start":355,"enrollment":26,"conditions":468,"interventions":469},[65],[14],[432,451],{"trials":471,"activeCount":73},[],{"intervention":473,"totalTrials":69,"cells":474},"air",{"EARLY_PHASE1":475,"PHASE1":477,"PHASE2":479,"PHASE3":481,"PHASE4":483,"NA":495},{"trials":476,"activeCount":73},[],{"trials":478,"activeCount":73},[],{"trials":480,"activeCount":73},[],{"trials":482,"activeCount":73},[],{"trials":484,"activeCount":73},[485],{"nctId":486,"briefTitle":487,"status":352,"phases":488,"primaryCompletion":489,"completion":489,"start":490,"enrollment":491,"conditions":492,"interventions":493},"NCT00547209","Effect of Nitrous Oxide on Intravenous Closed-loop Anesthesia",[65],"2009-11","2007-10",672,[14],[473,494],"Nitrous oxide",{"trials":496,"activeCount":73},[],{"intervention":494,"totalTrials":69,"cells":498},{"EARLY_PHASE1":499,"PHASE1":501,"PHASE2":503,"PHASE3":505,"PHASE4":507,"NA":513},{"trials":500,"activeCount":73},[],{"trials":502,"activeCount":73},[],{"trials":504,"activeCount":73},[],{"trials":506,"activeCount":73},[],{"trials":508,"activeCount":73},[509],{"nctId":486,"briefTitle":487,"status":352,"phases":510,"primaryCompletion":489,"completion":489,"start":490,"enrollment":491,"conditions":511,"interventions":512},[65],[14],[473,494],{"trials":514,"activeCount":73},[],{"intervention":516,"totalTrials":69,"cells":517},"Propofol (Astra-Zeneca), NaCl 0.9%",{"EARLY_PHASE1":518,"PHASE1":520,"PHASE2":522,"PHASE3":524,"PHASE4":526,"NA":540},{"trials":519,"activeCount":73},[],{"trials":521,"activeCount":73},[],{"trials":523,"activeCount":73},[],{"trials":525,"activeCount":73},[],{"trials":527,"activeCount":73},[528],{"nctId":529,"briefTitle":530,"status":352,"phases":531,"primaryCompletion":532,"completion":532,"start":424,"enrollment":533,"conditions":534,"interventions":535},"NCT01592162","Comparison of Different Propofol Formulations With or Without Remifentanil",[65],"2014-11",409,[14],[516,536,536,516,537,537,538,539,539],"propofol 1% (Astra-Zeneca) and remifentanil","Propofol (Astra-Zeneca) and remifentanil","Propofol (B-Braun) and NaCl 0.9%","Propofol (B-Braun) and remifentanil",{"trials":541,"activeCount":73},[],{"intervention":536,"totalTrials":69,"cells":543},{"EARLY_PHASE1":544,"PHASE1":546,"PHASE2":548,"PHASE3":550,"PHASE4":552,"NA":558},{"trials":545,"activeCount":73},[],{"trials":547,"activeCount":73},[],{"trials":549,"activeCount":73},[],{"trials":551,"activeCount":73},[],{"trials":553,"activeCount":73},[554],{"nctId":529,"briefTitle":530,"status":352,"phases":555,"primaryCompletion":532,"completion":532,"start":424,"enrollment":533,"conditions":556,"interventions":557},[65],[14],[516,536,536,516,537,537,538,539,539],{"trials":559,"activeCount":73},[],{"intervention":537,"totalTrials":69,"cells":561},{"EARLY_PHASE1":562,"PHASE1":564,"PHASE2":566,"PHASE3":568,"PHASE4":570,"NA":576},{"trials":563,"activeCount":73},[],{"trials":565,"activeCount":73},[],{"trials":567,"activeCount":73},[],{"trials":569,"activeCount":73},[],{"trials":571,"activeCount":73},[572],{"nctId":529,"briefTitle":530,"status":352,"phases":573,"primaryCompletion":532,"completion":532,"start":424,"enrollment":533,"conditions":574,"interventions":575},[65],[14],[516,536,536,516,537,537,538,539,539],{"trials":577,"activeCount":73},[],{"intervention":538,"totalTrials":69,"cells":579},{"EARLY_PHASE1":580,"PHASE1":582,"PHASE2":584,"PHASE3":586,"PHASE4":588,"NA":594},{"trials":581,"activeCount":73},[],{"trials":583,"activeCount":73},[],{"trials":585,"activeCount":73},[],{"trials":587,"activeCount":73},[],{"trials":589,"activeCount":73},[590],{"nctId":529,"briefTitle":530,"status":352,"phases":591,"primaryCompletion":532,"completion":532,"start":424,"enrollment":533,"conditions":592,"interventions":593},[65],[14],[516,536,536,516,537,537,538,539,539],{"trials":595,"activeCount":73},[],{"intervention":539,"totalTrials":69,"cells":597},{"EARLY_PHASE1":598,"PHASE1":600,"PHASE2":602,"PHASE3":604,"PHASE4":606,"NA":612},{"trials":599,"activeCount":73},[],{"trials":601,"activeCount":73},[],{"trials":603,"activeCount":73},[],{"trials":605,"activeCount":73},[],{"trials":607,"activeCount":73},[608],{"nctId":529,"briefTitle":530,"status":352,"phases":609,"primaryCompletion":532,"completion":532,"start":424,"enrollment":533,"conditions":610,"interventions":611},[65],[14],[516,536,536,516,537,537,538,539,539],{"trials":613,"activeCount":73},[],{"intervention":615,"totalTrials":69,"cells":616},"Propofol Astrazeneca plain",{"EARLY_PHASE1":617,"PHASE1":619,"PHASE2":621,"PHASE3":623,"PHASE4":625,"NA":640},{"trials":618,"activeCount":73},[],{"trials":620,"activeCount":73},[],{"trials":622,"activeCount":73},[],{"trials":624,"activeCount":73},[],{"trials":626,"activeCount":73},[627],{"nctId":628,"briefTitle":629,"status":352,"phases":630,"primaryCompletion":285,"completion":285,"start":631,"enrollment":632,"conditions":633,"interventions":634},"NCT01041872","Comparison of Different Propofol Formulations",[65],"2009-12",212,[25],[615,635,636,637,638,639],"Propofol Astrazeneca plus lidocaine","Propofol-lipuro B. Braun plain","Propofol-lipuro B. Braun plus lidocaine","Propofol Fresenius plain","Propofol Fresenius plus lidocaine",{"trials":641,"activeCount":73},[],{"intervention":635,"totalTrials":69,"cells":643},{"EARLY_PHASE1":644,"PHASE1":646,"PHASE2":648,"PHASE3":650,"PHASE4":652,"NA":658},{"trials":645,"activeCount":73},[],{"trials":647,"activeCount":73},[],{"trials":649,"activeCount":73},[],{"trials":651,"activeCount":73},[],{"trials":653,"activeCount":73},[654],{"nctId":628,"briefTitle":629,"status":352,"phases":655,"primaryCompletion":285,"completion":285,"start":631,"enrollment":632,"conditions":656,"interventions":657},[65],[25],[615,635,636,637,638,639],{"trials":659,"activeCount":73},[],{"intervention":636,"totalTrials":69,"cells":661},{"EARLY_PHASE1":662,"PHASE1":664,"PHASE2":666,"PHASE3":668,"PHASE4":670,"NA":676},{"trials":663,"activeCount":73},[],{"trials":665,"activeCount":73},[],{"trials":667,"activeCount":73},[],{"trials":669,"activeCount":73},[],{"trials":671,"activeCount":73},[672],{"nctId":628,"briefTitle":629,"status":352,"phases":673,"primaryCompletion":285,"completion":285,"start":631,"enrollment":632,"conditions":674,"interventions":675},[65],[25],[615,635,636,637,638,639],{"trials":677,"activeCount":73},[],{"intervention":637,"totalTrials":69,"cells":679},{"EARLY_PHASE1":680,"PHASE1":682,"PHASE2":684,"PHASE3":686,"PHASE4":688,"NA":694},{"trials":681,"activeCount":73},[],{"trials":683,"activeCount":73},[],{"trials":685,"activeCount":73},[],{"trials":687,"activeCount":73},[],{"trials":689,"activeCount":73},[690],{"nctId":628,"briefTitle":629,"status":352,"phases":691,"primaryCompletion":285,"completion":285,"start":631,"enrollment":632,"conditions":692,"interventions":693},[65],[25],[615,635,636,637,638,639],{"trials":695,"activeCount":73},[],{"intervention":638,"totalTrials":69,"cells":697},{"EARLY_PHASE1":698,"PHASE1":700,"PHASE2":702,"PHASE3":704,"PHASE4":706,"NA":712},{"trials":699,"activeCount":73},[],{"trials":701,"activeCount":73},[],{"trials":703,"activeCount":73},[],{"trials":705,"activeCount":73},[],{"trials":707,"activeCount":73},[708],{"nctId":628,"briefTitle":629,"status":352,"phases":709,"primaryCompletion":285,"completion":285,"start":631,"enrollment":632,"conditions":710,"interventions":711},[65],[25],[615,635,636,637,638,639],{"trials":713,"activeCount":73},[],{"intervention":639,"totalTrials":69,"cells":715},{"EARLY_PHASE1":716,"PHASE1":718,"PHASE2":720,"PHASE3":722,"PHASE4":724,"NA":730},{"trials":717,"activeCount":73},[],{"trials":719,"activeCount":73},[],{"trials":721,"activeCount":73},[],{"trials":723,"activeCount":73},[],{"trials":725,"activeCount":73},[726],{"nctId":628,"briefTitle":629,"status":352,"phases":727,"primaryCompletion":285,"completion":285,"start":631,"enrollment":632,"conditions":728,"interventions":729},[65],[25],[615,635,636,637,638,639],{"trials":731,"activeCount":73},[],{"intervention":733,"totalTrials":69,"cells":734},"tranexamic acid",{"EARLY_PHASE1":735,"PHASE1":737,"PHASE2":739,"PHASE3":741,"PHASE4":743,"NA":756},{"trials":736,"activeCount":73},[],{"trials":738,"activeCount":73},[],{"trials":740,"activeCount":73},[],{"trials":742,"activeCount":73},[],{"trials":744,"activeCount":73},[745],{"nctId":746,"briefTitle":747,"status":352,"phases":748,"primaryCompletion":749,"completion":749,"start":750,"enrollment":751,"conditions":752,"interventions":755},"NCT00809393","Dose-ranging Study of Two Doses of Tranexamic Acid During Cardiac Surgery",[65],"2011-01","2009-02",600,[753,754],"Cardiopulmonary Bypass","Hemorrhage",[733,733],{"trials":757,"activeCount":73},[],{"intervention":759,"totalTrials":69,"cells":760},"Sugammadex - Nacl 9\u002F00",{"EARLY_PHASE1":761,"PHASE1":763,"PHASE2":765,"PHASE3":767,"PHASE4":769,"NA":780},{"trials":762,"activeCount":73},[],{"trials":764,"activeCount":73},[],{"trials":766,"activeCount":73},[],{"trials":768,"activeCount":73},[],{"trials":770,"activeCount":73},[771],{"nctId":772,"briefTitle":773,"status":352,"phases":774,"primaryCompletion":775,"completion":775,"start":286,"enrollment":776,"conditions":777,"interventions":778},"NCT01161004","Recovery Effect of Sugammadex Measured by Bispectral and Neurosense Indices",[65],"2011-08",50,[14],[759,779],"Nacl 9\u002F00 - sugammadex",{"trials":781,"activeCount":73},[],{"intervention":779,"totalTrials":69,"cells":783},{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":790,"PHASE4":792,"NA":798},{"trials":785,"activeCount":73},[],{"trials":787,"activeCount":73},[],{"trials":789,"activeCount":73},[],{"trials":791,"activeCount":73},[],{"trials":793,"activeCount":73},[794],{"nctId":772,"briefTitle":773,"status":352,"phases":795,"primaryCompletion":775,"completion":775,"start":286,"enrollment":776,"conditions":796,"interventions":797},[65],[14],[759,779],{"trials":799,"activeCount":73},[],{"intervention":801,"totalTrials":69,"cells":802},"Open loop",{"EARLY_PHASE1":803,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":811,"NA":821},{"trials":804,"activeCount":73},[],{"trials":806,"activeCount":73},[],{"trials":808,"activeCount":73},[],{"trials":810,"activeCount":73},[],{"trials":812,"activeCount":73},[813],{"nctId":814,"briefTitle":815,"status":272,"phases":816,"primaryCompletion":817,"completion":817,"start":818,"enrollment":259,"conditions":819,"interventions":820},"NCT01882075","Closed-loop Fluid Administration System: Pilot Study to Evaluate Feasibility",[65],"2014-12","2013-06",[14],[801],{"trials":822,"activeCount":73},[],{"intervention":824,"totalTrials":69,"cells":825},"Chirocaine",{"EARLY_PHASE1":826,"PHASE1":828,"PHASE2":830,"PHASE3":832,"PHASE4":834,"NA":847},{"trials":827,"activeCount":73},[],{"trials":829,"activeCount":73},[],{"trials":831,"activeCount":73},[],{"trials":833,"activeCount":73},[],{"trials":835,"activeCount":73},[836],{"nctId":837,"briefTitle":838,"status":352,"phases":839,"primaryCompletion":354,"completion":840,"start":749,"enrollment":841,"conditions":842,"interventions":846},"NCT02905695","Post-partum Perineal Pain - Chirocaine®",[65],"2016-07",110,[843,844,845],"Post-partum Perineal Pain","Episiotomy","Vaginal Tear",[824],{"trials":848,"activeCount":73},[],{"intervention":850,"totalTrials":259,"cells":851},"NaCl 9\u002F00",{"EARLY_PHASE1":852,"PHASE1":854,"PHASE2":856,"PHASE3":858,"PHASE4":878,"NA":880},{"trials":853,"activeCount":73},[],{"trials":855,"activeCount":73},[],{"trials":857,"activeCount":73},[],{"trials":859,"activeCount":73},[860,869],{"nctId":861,"briefTitle":862,"status":352,"phases":863,"primaryCompletion":285,"completion":285,"start":864,"enrollment":865,"conditions":866,"interventions":867},"NCT00921284","Influence of Dexmedetomidine on a Closed-Loop Anesthesia System",[64],"2009-06",66,[14],[850,868],"dexmedetomidine",{"nctId":870,"briefTitle":871,"status":272,"phases":872,"primaryCompletion":631,"completion":873,"start":864,"enrollment":874,"conditions":875,"interventions":876},"NCT00922467","Influence of Esmolol on a Closed-Loop Anesthesia System",[64],"2011-12",15,[14],[850,877],"Esmolol",{"trials":879,"activeCount":73},[],{"trials":881,"activeCount":73},[],{"intervention":883,"totalTrials":69,"cells":884},"muscle relaxant",{"EARLY_PHASE1":885,"PHASE1":887,"PHASE2":889,"PHASE3":891,"PHASE4":902,"NA":904},{"trials":886,"activeCount":73},[],{"trials":888,"activeCount":73},[],{"trials":890,"activeCount":73},[],{"trials":892,"activeCount":73},[893],{"nctId":894,"briefTitle":895,"status":352,"phases":896,"primaryCompletion":897,"completion":897,"start":631,"enrollment":898,"conditions":899,"interventions":900},"NCT00886418","Influence of Muscle Relaxation on a Closed-loop Anesthesia System",[64],"2015-02",140,[23],[883,901],"normal saline",{"trials":903,"activeCount":73},[],{"trials":905,"activeCount":73},[],{"intervention":901,"totalTrials":69,"cells":907},{"EARLY_PHASE1":908,"PHASE1":910,"PHASE2":912,"PHASE3":914,"PHASE4":920,"NA":922},{"trials":909,"activeCount":73},[],{"trials":911,"activeCount":73},[],{"trials":913,"activeCount":73},[],{"trials":915,"activeCount":73},[916],{"nctId":894,"briefTitle":895,"status":352,"phases":917,"primaryCompletion":897,"completion":897,"start":631,"enrollment":898,"conditions":918,"interventions":919},[64],[23],[883,901],{"trials":921,"activeCount":73},[],{"trials":923,"activeCount":73},[],{"intervention":868,"totalTrials":69,"cells":925},{"EARLY_PHASE1":926,"PHASE1":928,"PHASE2":930,"PHASE3":932,"PHASE4":938,"NA":940},{"trials":927,"activeCount":73},[],{"trials":929,"activeCount":73},[],{"trials":931,"activeCount":73},[],{"trials":933,"activeCount":73},[934],{"nctId":861,"briefTitle":862,"status":352,"phases":935,"primaryCompletion":285,"completion":285,"start":864,"enrollment":865,"conditions":936,"interventions":937},[64],[14],[850,868],{"trials":939,"activeCount":73},[],{"trials":941,"activeCount":73},[],{"intervention":877,"totalTrials":69,"cells":943},{"EARLY_PHASE1":944,"PHASE1":946,"PHASE2":948,"PHASE3":950,"PHASE4":956,"NA":958},{"trials":945,"activeCount":73},[],{"trials":947,"activeCount":73},[],{"trials":949,"activeCount":73},[],{"trials":951,"activeCount":73},[952],{"nctId":870,"briefTitle":871,"status":272,"phases":953,"primaryCompletion":631,"completion":873,"start":864,"enrollment":874,"conditions":954,"interventions":955},[64],[14],[850,877],{"trials":957,"activeCount":73},[],{"trials":959,"activeCount":73},[],{"intervention":961,"totalTrials":69,"cells":962},"Everolimus",{"EARLY_PHASE1":963,"PHASE1":965,"PHASE2":967,"PHASE3":979,"PHASE4":981,"NA":983},{"trials":964,"activeCount":73},[],{"trials":966,"activeCount":73},[],{"trials":968,"activeCount":73},[969],{"nctId":970,"briefTitle":971,"status":352,"phases":972,"primaryCompletion":973,"completion":973,"start":974,"enrollment":975,"conditions":976,"interventions":978},"NCT01801137","The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium",[63],"2014-10","2011-06",54,[977],"Urothelial Cancer",[961],{"trials":980,"activeCount":73},[],{"trials":982,"activeCount":73},[],{"trials":984,"activeCount":73},[],{"intervention":986,"totalTrials":69,"cells":987},"Botulinum toxin A",{"EARLY_PHASE1":988,"PHASE1":990,"PHASE2":992,"PHASE3":1005,"PHASE4":1007,"NA":1009},{"trials":989,"activeCount":73},[],{"trials":991,"activeCount":73},[],{"trials":993,"activeCount":73},[994],{"nctId":995,"briefTitle":996,"status":352,"phases":997,"primaryCompletion":998,"completion":998,"start":974,"enrollment":999,"conditions":1000,"interventions":1004},"NCT02986880","Effect of Type-A Botulinum Toxin in the Post-radiosurgical Neck Contractures",[63],"2014-01-10",14,[1001,1002,1003],"Cervical Spasm","Radiotherapy Side Effect","Botulinum Toxin",[986],{"trials":1006,"activeCount":73},[],{"trials":1008,"activeCount":73},[],{"trials":1010,"activeCount":73},[],{"intervention":1012,"totalTrials":29,"cells":1013},"remifentanil",{"EARLY_PHASE1":1014,"PHASE1":1016,"PHASE2":1018,"PHASE3":1020,"PHASE4":1022,"NA":1053},{"trials":1015,"activeCount":73},[],{"trials":1017,"activeCount":73},[],{"trials":1019,"activeCount":73},[],{"trials":1021,"activeCount":73},[],{"trials":1023,"activeCount":73},[1024,1035,1044],{"nctId":1025,"briefTitle":1026,"status":272,"phases":1027,"primaryCompletion":1028,"completion":1028,"start":1029,"enrollment":1030,"conditions":1031,"interventions":1032},"NCT00778505","Use of Closed-loop Anesthesia in Pediatric Patients",[65],"2012-12","2008-10",45,[14],[1033,1012,1033,1034],"Propofol","Remifentanil",{"nctId":1036,"briefTitle":1037,"status":352,"phases":1038,"primaryCompletion":1039,"completion":749,"start":1040,"enrollment":1041,"conditions":1042,"interventions":1043},"NCT00772616","Influence of Intraoperative Analgesia on the Postoperative Morphine Consumption",[65],"2010-01","2008-09",60,[14],[1034,290],{"nctId":1045,"briefTitle":1046,"status":352,"phases":1047,"primaryCompletion":1048,"completion":749,"start":1049,"enrollment":1050,"conditions":1051,"interventions":1052},"NCT00627081","Effect of Thoracic Epidural Analgesia on Intravenous Closed-Loop Anesthesia",[65],"2010-12","2008-02",40,[25],[1012],{"trials":1054,"activeCount":73},[1055],{"nctId":1056,"briefTitle":1057,"status":272,"phases":1058,"primaryCompletion":1059,"completion":1059,"start":1060,"enrollment":1061,"conditions":1062,"interventions":1064},"NCT02488486","Postoperative Sedation After Cardiac Surgery",[66],"2017-05","2015-05",19,[1063,14],"Surgery, Cardiac",[1065,1012],"propofol",{"intervention":290,"totalTrials":1067,"cells":1068},3,{"EARLY_PHASE1":1069,"PHASE1":1071,"PHASE2":1073,"PHASE3":1075,"PHASE4":1077,"NA":1087},{"trials":1070,"activeCount":73},[],{"trials":1072,"activeCount":73},[],{"trials":1074,"activeCount":73},[],{"trials":1076,"activeCount":73},[],{"trials":1078,"activeCount":73},[1079,1083],{"nctId":282,"briefTitle":283,"status":272,"phases":1080,"primaryCompletion":285,"completion":285,"start":286,"enrollment":259,"conditions":1081,"interventions":1082},[65],[288],[290,258],{"nctId":1036,"briefTitle":1037,"status":352,"phases":1084,"primaryCompletion":1039,"completion":749,"start":1040,"enrollment":1041,"conditions":1085,"interventions":1086},[65],[14],[1034,290],{"trials":1088,"activeCount":73},[1089],{"nctId":1090,"briefTitle":1091,"status":272,"phases":1092,"primaryCompletion":1093,"completion":1093,"start":873,"enrollment":1094,"conditions":1095,"interventions":1097},"NCT01505283","Effect of Epidural Analgesia on the Parameter ANI During Childbirth",[66],"2015-07",42,[1096],"Labor Pain",[1098,290,1099],"NaCl 0.9%","lidocaine",{"intervention":1065,"totalTrials":1067,"cells":1101},{"EARLY_PHASE1":1102,"PHASE1":1104,"PHASE2":1106,"PHASE3":1108,"PHASE4":1110,"NA":1116},{"trials":1103,"activeCount":73},[],{"trials":1105,"activeCount":73},[],{"trials":1107,"activeCount":73},[],{"trials":1109,"activeCount":73},[],{"trials":1111,"activeCount":73},[1112],{"nctId":1025,"briefTitle":1026,"status":272,"phases":1113,"primaryCompletion":1028,"completion":1028,"start":1029,"enrollment":1030,"conditions":1114,"interventions":1115},[65],[14],[1033,1012,1033,1034],{"trials":1117,"activeCount":73},[1118,1122],{"nctId":1056,"briefTitle":1057,"status":272,"phases":1119,"primaryCompletion":1059,"completion":1059,"start":1060,"enrollment":1061,"conditions":1120,"interventions":1121},[66],[1063,14],[1065,1012],{"nctId":1123,"briefTitle":1124,"status":352,"phases":1125,"primaryCompletion":1126,"completion":1126,"start":1127,"enrollment":1128,"conditions":1129,"interventions":1130},"NCT02249364","Hypnosis Before the Induction of Anesthesia",[66],"2015-12","2014-04",80,[14],[1065],{"intervention":1099,"totalTrials":259,"cells":1132},{"EARLY_PHASE1":1133,"PHASE1":1135,"PHASE2":1137,"PHASE3":1139,"PHASE4":1149,"NA":1151},{"trials":1134,"activeCount":73},[],{"trials":1136,"activeCount":73},[],{"trials":1138,"activeCount":73},[],{"trials":1140,"activeCount":73},[1141],{"nctId":1142,"briefTitle":1143,"status":352,"phases":1144,"primaryCompletion":354,"completion":354,"start":749,"enrollment":1145,"conditions":1146,"interventions":1147},"NCT01154738","Lidocaine and Closed-Loop Anesthesia System",[64],82,[14],[1148],"Lidocaine",{"trials":1150,"activeCount":73},[],{"trials":1152,"activeCount":73},[1153],{"nctId":1090,"briefTitle":1091,"status":272,"phases":1154,"primaryCompletion":1093,"completion":1093,"start":873,"enrollment":1094,"conditions":1155,"interventions":1156},[66],[1096],[1098,290,1099],{"intervention":1158,"totalTrials":69,"cells":1159},"propofol, remifentanil, atracurium",{"EARLY_PHASE1":1160,"PHASE1":1162,"PHASE2":1164,"PHASE3":1166,"PHASE4":1168,"NA":1170},{"trials":1161,"activeCount":73},[],{"trials":1163,"activeCount":73},[],{"trials":1165,"activeCount":73},[],{"trials":1167,"activeCount":73},[],{"trials":1169,"activeCount":73},[],{"trials":1171,"activeCount":73},[1172],{"nctId":1173,"briefTitle":1174,"status":272,"phases":1175,"primaryCompletion":1048,"completion":1048,"start":1176,"enrollment":1050,"conditions":1177,"interventions":1178},"NCT00910416","The Comparability of Bispectral Index and Neurosense During Anesthesia",[],"2009-05",[14],[1158,1179],"propofol, remifentanil, atracurium, sevoflurane",{"intervention":1179,"totalTrials":69,"cells":1181},{"EARLY_PHASE1":1182,"PHASE1":1184,"PHASE2":1186,"PHASE3":1188,"PHASE4":1190,"NA":1192},{"trials":1183,"activeCount":73},[],{"trials":1185,"activeCount":73},[],{"trials":1187,"activeCount":73},[],{"trials":1189,"activeCount":73},[],{"trials":1191,"activeCount":73},[],{"trials":1193,"activeCount":73},[1194],{"nctId":1173,"briefTitle":1174,"status":272,"phases":1195,"primaryCompletion":1048,"completion":1048,"start":1176,"enrollment":1050,"conditions":1196,"interventions":1197},[],[14],[1158,1179],{"intervention":1199,"totalTrials":69,"cells":1200},"Ropivacaine 0.5%",{"EARLY_PHASE1":1201,"PHASE1":1203,"PHASE2":1205,"PHASE3":1207,"PHASE4":1209,"NA":1211},{"trials":1202,"activeCount":73},[],{"trials":1204,"activeCount":73},[],{"trials":1206,"activeCount":73},[],{"trials":1208,"activeCount":73},[],{"trials":1210,"activeCount":73},[],{"trials":1212,"activeCount":73},[1213],{"nctId":1214,"briefTitle":1215,"status":352,"phases":1216,"primaryCompletion":1217,"completion":1217,"start":1218,"enrollment":1219,"conditions":1220,"interventions":1222},"NCT02663284","Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome",[66],"2014-03","2012-04",30,[1221],"Complex Regional Pain Syndrome",[1199],{"intervention":1224,"totalTrials":69,"cells":1225},"Blood sample",{"EARLY_PHASE1":1226,"PHASE1":1228,"PHASE2":1230,"PHASE3":1232,"PHASE4":1234,"NA":1236},{"trials":1227,"activeCount":73},[],{"trials":1229,"activeCount":73},[],{"trials":1231,"activeCount":73},[],{"trials":1233,"activeCount":73},[],{"trials":1235,"activeCount":73},[],{"trials":1237,"activeCount":73},[1238],{"nctId":1239,"briefTitle":1240,"status":1241,"phases":1242,"primaryCompletion":1243,"completion":1243,"start":1244,"enrollment":1041,"conditions":1245,"interventions":1248},"NCT02850692","Portal Hypertension and Systemic Endothelial Function","UNKNOWN",[66],"2021-12","2016-04-18",[1246,1247],"Cystic Fibrosis","Portal Hypertension",[1224],{"intervention":1250,"totalTrials":69,"cells":1251},"steroids concentrations determination",{"EARLY_PHASE1":1252,"PHASE1":1254,"PHASE2":1256,"PHASE3":1258,"PHASE4":1260,"NA":1262},{"trials":1253,"activeCount":73},[],{"trials":1255,"activeCount":73},[],{"trials":1257,"activeCount":73},[],{"trials":1259,"activeCount":73},[],{"trials":1261,"activeCount":73},[],{"trials":1263,"activeCount":73},[1264],{"nctId":1265,"briefTitle":1266,"status":352,"phases":1267,"primaryCompletion":1268,"completion":1268,"start":1269,"enrollment":1270,"conditions":1271,"interventions":1274},"NCT02778243","Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level",[66],"2016-11-12","2014-09",107,[1272,1273],"Urinary Bladder Neoplasms","Prostate Hyperplasia",[1250],{"intervention":1098,"totalTrials":69,"cells":1276},{"EARLY_PHASE1":1277,"PHASE1":1279,"PHASE2":1281,"PHASE3":1283,"PHASE4":1285,"NA":1287},{"trials":1278,"activeCount":73},[],{"trials":1280,"activeCount":73},[],{"trials":1282,"activeCount":73},[],{"trials":1284,"activeCount":73},[],{"trials":1286,"activeCount":73},[],{"trials":1288,"activeCount":73},[1289],{"nctId":1090,"briefTitle":1091,"status":272,"phases":1290,"primaryCompletion":1093,"completion":1093,"start":873,"enrollment":1094,"conditions":1291,"interventions":1292},[66],[1096],[1098,290,1099],{"intervention":1294,"totalTrials":69,"cells":1295},"Blood test for detecting the circulatory anti-HLA antibodies by ELISA and LUMINEX tests",{"EARLY_PHASE1":1296,"PHASE1":1298,"PHASE2":1300,"PHASE3":1302,"PHASE4":1304,"NA":1306},{"trials":1297,"activeCount":73},[],{"trials":1299,"activeCount":73},[],{"trials":1301,"activeCount":73},[],{"trials":1303,"activeCount":73},[],{"trials":1305,"activeCount":73},[],{"trials":1307,"activeCount":73},[1308],{"nctId":1309,"briefTitle":1310,"status":352,"phases":1311,"primaryCompletion":1312,"completion":1313,"start":1314,"enrollment":1315,"conditions":1316,"interventions":1317},"NCT01791166","Immuno-humoral Rejection Markers in Pulmonary Transplant",[66],"2013-10","2014-07","2011-02",53,[33],[1294],{"intervention":1319,"totalTrials":69,"cells":1320},"Propofol and remifentanil anesthesia",{"EARLY_PHASE1":1321,"PHASE1":1323,"PHASE2":1325,"PHASE3":1327,"PHASE4":1329,"NA":1331},{"trials":1322,"activeCount":73},[],{"trials":1324,"activeCount":73},[],{"trials":1326,"activeCount":73},[],{"trials":1328,"activeCount":73},[],{"trials":1330,"activeCount":73},[],{"trials":1332,"activeCount":73},[1333],{"nctId":1334,"briefTitle":1335,"status":352,"phases":1336,"primaryCompletion":897,"completion":897,"start":1269,"enrollment":776,"conditions":1337,"interventions":1339},"NCT02245789","Does the Use of a Videolaryngoscope Modifies Anesthetic Induction ?",[66],[1338],"Tracheal Intubation",[1319],{"intervention":1341,"totalTrials":69,"cells":1342},"Biological sample",{"EARLY_PHASE1":1343,"PHASE1":1345,"PHASE2":1347,"PHASE3":1349,"PHASE4":1351,"NA":1353},{"trials":1344,"activeCount":73},[],{"trials":1346,"activeCount":73},[],{"trials":1348,"activeCount":73},[],{"trials":1350,"activeCount":73},[],{"trials":1352,"activeCount":73},[],{"trials":1354,"activeCount":73},[1355],{"nctId":1356,"briefTitle":1357,"status":352,"phases":1358,"primaryCompletion":1359,"completion":1359,"start":749,"enrollment":1360,"conditions":1361,"interventions":1363},"NCT02951442","Identification of Markers (Klotho-FGF23 Axis) as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant",[66],"2014-01-28",117,[1362],"Renal Transplant",[1341],{"intervention":1365,"totalTrials":69,"cells":1366},"Determination of Anti-Rubella Antibody, E1",{"EARLY_PHASE1":1367,"PHASE1":1369,"PHASE2":1371,"PHASE3":1373,"PHASE4":1375,"NA":1377},{"trials":1368,"activeCount":73},[],{"trials":1370,"activeCount":73},[],{"trials":1372,"activeCount":73},[],{"trials":1374,"activeCount":73},[],{"trials":1376,"activeCount":73},[],{"trials":1378,"activeCount":73},[1379],{"nctId":1380,"briefTitle":1381,"status":352,"phases":1382,"primaryCompletion":1383,"completion":973,"start":1384,"enrollment":1385,"conditions":1386,"interventions":1388},"NCT02934295","Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies",[66],"2014-05","2012-02",192,[1387],"Pregnancy",[1365],{"intervention":1390,"totalTrials":69,"cells":1391},"intra-prostatic concentration of sexual steroids",{"EARLY_PHASE1":1392,"PHASE1":1394,"PHASE2":1396,"PHASE3":1398,"PHASE4":1400,"NA":1402},{"trials":1393,"activeCount":73},[],{"trials":1395,"activeCount":73},[],{"trials":1397,"activeCount":73},[],{"trials":1399,"activeCount":73},[],{"trials":1401,"activeCount":73},[],{"trials":1403,"activeCount":73},[1404],{"nctId":1405,"briefTitle":1406,"status":1407,"phases":1408,"primaryCompletion":1409,"completion":1410,"start":1411,"enrollment":73,"conditions":1412,"interventions":1414},"NCT03014973","Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status","WITHDRAWN",[66],"2018-06","2018-12","2017-01",[1413],"Prostate Cancer",[1390],{"intervention":1416,"totalTrials":69,"cells":1417},"Ringer solution",{"EARLY_PHASE1":1418,"PHASE1":1420,"PHASE2":1422,"PHASE3":1424,"PHASE4":1426,"NA":1428},{"trials":1419,"activeCount":73},[],{"trials":1421,"activeCount":73},[],{"trials":1423,"activeCount":73},[],{"trials":1425,"activeCount":73},[],{"trials":1427,"activeCount":73},[],{"trials":1429,"activeCount":73},[1430],{"nctId":1431,"briefTitle":1432,"status":272,"phases":1433,"primaryCompletion":1434,"completion":1434,"start":1435,"enrollment":259,"conditions":1436,"interventions":1437},"NCT02485457","Validation of Nicom Device to Measure Stoke Volume Variation",[66],"2017-06-12","2015-06-28",[14],[1416],{"intervention":1439,"totalTrials":69,"cells":1440},"Peripheral venous blood samples",{"EARLY_PHASE1":1441,"PHASE1":1443,"PHASE2":1445,"PHASE3":1447,"PHASE4":1449,"NA":1451},{"trials":1442,"activeCount":73},[],{"trials":1444,"activeCount":73},[],{"trials":1446,"activeCount":73},[],{"trials":1448,"activeCount":73},[],{"trials":1450,"activeCount":73},[],{"trials":1452,"activeCount":73},[1453],{"nctId":1454,"briefTitle":1455,"status":352,"phases":1456,"primaryCompletion":1457,"completion":1458,"start":1459,"enrollment":1460,"conditions":1461,"interventions":1466},"NCT05523713","Development and Validation of a Predictive Score for Surgical Site Infections",[66],"2023-11-29","2025-01-27","2022-10-06",283,[1462,1463,1464,1465],"Colon or Colorectal Resection","Partial or Total Gastrectomy","Pancreaticoduodenectomy","Hepatectomy",[1439],{"intervention":1468,"totalTrials":69,"cells":1469},"Combined contact aspiration\u002FStent Retriever Technique",{"EARLY_PHASE1":1470,"PHASE1":1472,"PHASE2":1474,"PHASE3":1476,"PHASE4":1478,"NA":1480},{"trials":1471,"activeCount":73},[],{"trials":1473,"activeCount":73},[],{"trials":1475,"activeCount":73},[],{"trials":1477,"activeCount":73},[],{"trials":1479,"activeCount":73},[],{"trials":1481,"activeCount":73},[1482],{"nctId":1483,"briefTitle":1484,"status":352,"phases":1485,"primaryCompletion":1486,"completion":1486,"start":1487,"enrollment":1488,"conditions":1489,"interventions":1491},"NCT03290885","Combined Use of Contact Aspiration and the Stent Retriever Technique Versus Stent Retriever Alone for Recanalisation in Acute Cerebral Infarction",[66],"2020-02-28","2017-10-16",408,[1490],"Acute Ischemic Stroke",[1468],{"intervention":1493,"totalTrials":69,"cells":1494},"hemoglobin determination",{"EARLY_PHASE1":1495,"PHASE1":1497,"PHASE2":1499,"PHASE3":1501,"PHASE4":1503,"NA":1505},{"trials":1496,"activeCount":73},[],{"trials":1498,"activeCount":73},[],{"trials":1500,"activeCount":73},[],{"trials":1502,"activeCount":73},[],{"trials":1504,"activeCount":73},[],{"trials":1506,"activeCount":73},[1507],{"nctId":1508,"briefTitle":1509,"status":352,"phases":1510,"primaryCompletion":1511,"completion":1511,"start":864,"enrollment":1512,"conditions":1513,"interventions":1515},"NCT00912379","Hemoglobin Measured by MASIMO SpHb™ Device and Laboratory Measurement",[],"2010-04",300,[1514],"Patients' Assessment",[1493],{"intervention":1517,"totalTrials":69,"cells":1518},"Genetical analyses",{"EARLY_PHASE1":1519,"PHASE1":1521,"PHASE2":1523,"PHASE3":1525,"PHASE4":1527,"NA":1529},{"trials":1520,"activeCount":73},[],{"trials":1522,"activeCount":73},[],{"trials":1524,"activeCount":73},[],{"trials":1526,"activeCount":73},[],{"trials":1528,"activeCount":73},[],{"trials":1530,"activeCount":73},[1531],{"nctId":1532,"briefTitle":1533,"status":1407,"phases":1534,"primaryCompletion":1535,"completion":1536,"start":1537,"enrollment":73,"conditions":1538,"interventions":1540},"NCT02944721","Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer",[66],"2020-11","2021-04","2016-11",[1539],"Breast Cancer",[1517],{"intervention":1542,"totalTrials":69,"cells":1543},"Serological Test s for the Virus Chicken Pox Virus",{"EARLY_PHASE1":1544,"PHASE1":1546,"PHASE2":1548,"PHASE3":1550,"PHASE4":1552,"NA":1554},{"trials":1545,"activeCount":73},[],{"trials":1547,"activeCount":73},[],{"trials":1549,"activeCount":73},[],{"trials":1551,"activeCount":73},[],{"trials":1553,"activeCount":73},[],{"trials":1555,"activeCount":73},[1556],{"nctId":1557,"briefTitle":1558,"status":272,"phases":1559,"primaryCompletion":1560,"completion":1560,"start":1561,"enrollment":1562,"conditions":1563,"interventions":1564},"NCT02775422","Comparison of Serological Test s for the Virus Chicken Pox Virus (VZV) and Correlation With the Patient's Memory of the Infection or Vaccination",[66],"2020-07-26","2015-03-30",308,[1387],[1542]]